Answers are grounded in this paper and cite their sources.
The larger the decrease in PhA, the higher the risk of early mortality and incident CVD over the subsequent 18 years. PhA is a reliable and easy measure that may help identify those apparently healthy individuals who may be at increased risk of future CVD or dying prematurely. More studies are needed to confirm our results before it can be definitively concluded that PhA changes can improve clinical risk prediction.
No takes yet. Share an insight, caveat, or question.
Langer et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: